Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge



Rating:

Share or cite this content

Citations should be made in the following way:
H. Nilsson, D. Ambort, G. Hansson, H. Hebert (Huddinge, Gothenburg, Sweden). Molecular structure, packing and release of MUC2 with relevance to cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 4551

Member's Comments

No comment yet.

Related content which might interest you: Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Pharmacological treatment of the biochemical defect in cystic fibrosis airways Source: Eur Respir J 2001; 17: 1314-1321 Year: 2001 Primary ciliary dyskinesia and mild cystic fibrosis: lung structure and function similarities. Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 Pharmacology and regulation of ENaC function: implication in cystic fibrosis Source: Annual Congress 2009 - Novel regulators of alveolar liquid clearance Year: 2009 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis? Source: Breathe 2008; 4: 365 Year: 2008 Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence Source: Eur Respir J 2001; 17: 27-35 Year: 2001 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013 MiR-145 and SMAD3 expression in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids Source: Eur Respir J 2016; 48: 451-458 Year: 2016 The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013